Radoslaw Kaczmarek: Challenges Limiting Gene Therapy Use in Hemophilia
Radoslaw Kaczmarek, Researcher at IU School of Medicine and Hirszfeld Institute, shared an insightful review on X, reposting from The Video Journal of Hematology and Hematological Oncology:
”Thank you for having me The Video Journal of Hematology and Hematological Oncology.
Several colleagues and I also published a reflective article on this:
I summarized some key points in the video.
SPOILER ALERT
It is not due to lack of interest in gene therapy.”
Read the full article here.
Article: Why is the uptake of gene therapy in hemophilia less than expected?
Authors: Glenn F. Pierce, Mark Skinner, Brian O’Mahony, Dawn Rotellini, Radoslaw Kaczmarek
The Video Journal of Hematology and Hematological Oncology shared on X:
”Why has the uptake of gene therapy in hemophilia been less than expected? Is there limited interest in these therapies?
We caught up with Radoslaw Kaczmarek of Indiana University School of Medicine to get the answers to these questions.”
Watch the full interview.

Stay informed on all scientific advances in the field of genetics with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow